Validation of the Peripheral Trigger Point Theory of Migraine Headaches: Single-Surgeon Experience Using Botulinum Toxin and Surgical Decompression
Authors:
- Jeffrey E. JanisJeffrey E. Janis
- Arjun DhanikADArjun Dhanik
- Jessica H. HowardJHJessica H. Howard
- 1 July 2011
- journal article
- research article
- Published by Wolters Kluwer Health in Plastic and Reconstructive Surgery
- Vol. 128 (1) , 123-131
Abstract
Migraine headache is a widespread neurovascular disorder that is often suboptimally or incompletely treated. This article confirms the efficacy of botulinum toxin treatment with surgical decompression as a deactivator of migraine headache trigger sites through the retrospective analysis of a single surgeon's experience. A retrospective chart review was performed on 24 patients presenting with the diagnosis of migraine headache. Botulinum toxin type A injections were used to identify frontal, temporal, and/or occipital trigger points. The nasal trigger point was diagnosed with a decongestant trial, intranasal examination, and computed tomographic scan. Those patients with more than one trigger point underwent multiple surgical procedures, which were performed concomitantly during the same operation. All botulinum toxin injections, surgical procedures, and patient meetings were conducted by the principal investigator (J.E.J.), minimizing intrapatient treatment variability and multiprovider bias. Patient progress was tracked by consolidating migraine frequency, severity, and duration as a Migraine Headache Index. Nineteen patients (79.2 percent) benefited from surgery. Two patients (8.3 percent) reported migraine elimination and 17 patients (70.8 percent) reported significant improvement of their migraine symptoms. Among those patients who responded to surgery, average improvement from baseline levels was 96.9 percent. Among the entire patient population, average improvement was 78.2 percent from baseline. The mean postsurgical follow-up was 661 days. This study found botulinum toxin treatment with surgical decompression to be a potent deactivator of migraine headache trigger sites, corroborating the findings of the current literature in the field and underlining the reproducibility of the treatment. : Therapeutic, IV.(Figure is included in full-text article.).Keywords
This publication has 49 references indexed in Scilit:
- The Anatomy of the Greater Occipital Nerve: Part II. Compression Point TopographyPlastic and Reconstructive Surgery, 2010
- The Zygomaticotemporal Branch of the Trigeminal Nerve: Part II. Anatomical VariationsPlastic and Reconstructive Surgery, 2010
- Anatomy of the Auriculotemporal Nerve: Variations in Its Relationship to the Superficial Temporal Artery and Implications for the Treatment of Migraine HeadachesPlastic and Reconstructive Surgery, 2010
- A Placebo-Controlled Surgical Trial of the Treatment of Migraine HeadachesPlastic and Reconstructive Surgery, 2009
- Ten Lessons on the Epidemiology of MigraineHeadache: The Journal of Head and Face Pain, 2007
- The structure and mode of action of different botulinum toxinsEuropean Journal of Neurology, 2006
- Neurobiology of migraineNature Reviews Neuroscience, 2003
- Basilar Artery Migraine: Transcranial Doppler EEG and SPECT From the Aura Phase to the EndHeadache: The Journal of Head and Face Pain, 1997
- Transpalpebral Approach to the Corrugator Supercilii and Procerus MusclesPlastic and Reconstructive Surgery, 1995
- Acephalgic MigraineHeadache: The Journal of Head and Face Pain, 1986